Hospitals operate 24 hours a day, and it is assumed that critical decisions occur continuously around the clock. However, many aspects of hospital operation occur at particular times of day, including medical team rounding and shift changes. It is unclear if this impacts patient care, as an empirical account of 24 h treatment patterns is lacking. We analyzed the daily distribution of ~120K doses of 12 separate drugs in 1,486 inpatients at a major children's hospital in the U.S.
SIGNIFICANCE STATEMENT
The order and administration of hospital treatment was characterized by morning time surges and overnight lulls, regardless of drug type, diagnosis or care unit. As the first large-scale account of 24 h rhythms in hospital medicine, this study identifies a potential operational barrier to best clinical care. Critical clinical decisions should be made around the clock; pain, infection, hypertensive crisis, and other conditions do not occur selectively in the morning. Systemic bias in the timing of medicine is also at odds with circadian biology, which can influence when certain treatments are most effective or safe. Prevailing dogma is that hospital treatment is administered as needed regardless of time of day. Our findings challenge this notion and suggest that time of day in hospital operations deserves further consideration.
INTRODUCTION
Hospitals operate 24 hours a day year long. Caretakers are available around the clock, and it is assumed that critical treatment decisions occur continuously regardless of time of day.
However, many universal aspects of hospital operation occur at particular times of day, including medical team rounding and staff shift changes (1, 2) . It is unclear if this impacts patient care, as an empirical account of 24 h treatment patterns is lacking.
We conducted an observational cohort study to investigate whether the ordering or administration of hospital treatment is influenced by time of day. Blood pressure (BP) is a continuous phenotype universally tracked in an intensive care unit (ICU) setting. We analyzed the 24 h distribution of order and administration times in 1,481 patients who received at least one dose of hydralazine, a commonly used antihypertensive in the ICU, at a tertiary pediatric hospital from 2010 to 2017. Although hydralazine treatment was the basis for patient inclusion, our analysis also included 11 other drugs commonly administered to these patients.
We found that treatment was strongly time-of-day-dependent, characterized by distinct morning time surges and overnight lulls. Leveraging this large dataset of ~ 120K doses, we examined the 24 h distribution of order and administration times of multiple different drug classes, across different care units. Lastly, we explored the impact of dosing time on clinical outcomes.
RESULTS
Hydralazine is a vasodilator used to treat essential hypertension. We analyzed its daily use in 1,481 patients who received at least one intravenous (IV) dose of the drug. In total, 5,294 orders for IV hydralazine were placed, each stipulating a dosing frequency of "once", "as needed", or "scheduled" (Table 1 ). We tracked both order time (when a care provider replaces an electronic request for a drug) and dosing time (when the patient receives the drug) for each patient. Initial analyses considered only the first dose administered after each order (Methods).
Hydralazine order and first dosing times were non-uniformly distributed over 24 h (Kuiper' s test, P < 0.01), marked by distinct morning-time surges and overnight lulls ( Fig. 1A ). Nearly twice as many treatments were ordered (1, 495) and dosed (1, 445) between 10 AM to 4 PM compared to 2 AM-8 AM (783 and 899, respectively). The profiles were described by 24 h rhythms by three separate detection methods (cosinor analysis (3) , JTK_CYCLE (4) , and RAIN (5) , P < 0.05) Table 1 ). These rhythms were consistent across patient age groups and treatment units--ICU or general floor ( Fig. 2 ).
To determine if the 24 h rhythm in dosing of hydralazine reflected immediate medical need for treatment, we analyzed the systolic BP recording immediately prior to drug dosing (d-SBP) ( Fig. S 1A) . The majority (9/11) were described by 24 h rhythms (cosinor, P < 0.05; RAIN or JTK_CYCLE, P < 0.05), regardless of treatment unit ( SI Appendix, Table 1 and Our previous analyses included all order frequencies (once, scheduled, or as needed) but considered only the first dosing time from each order. Next, we analyzed scheduled orders only (e.g., "take every 8 h"), focusing on hydralazine as an example ( SI Appendix, Fig. S 2) . As expected, the first dosing times were rhythmically distributed. All subsequent dosing times, however, were uniformly distributed over 24 h, without discernible rhythms (cosinor analysis, P > 0.2). Time-of-day bias in the original ordering time, therefore, impacts all subsequent dosing times.
Rhythms in hospital medicine may conflict with circadian biology, as dosing time influences
responses to many types of treatment (6) . For example, in the outpatient setting, short-acting antihypertensives are most effective at lowering BP if taken before bedtime (7) . To test if this applies to acute antihypertensive therapy in the hospital, we analyzed inpatient responses to Table 2 for difference and confidence levels for pairwise comparisons). Both diastolic and systolic responses followed this pattern, although the variation in diastolic BP was more pronounced. In sum, nighttime hydralazine was associated with an ~ 3-4% greater reduction in diastolic BP on average than morning dosing (Tukey's test, difference = -3.4, 95% CI upper level = -5.5, lower level = -1.4, P-adjusted = 2e-06). We did not detect 24 h variation in response for any of the other three dosage groups, which included far fewer doses (SI Appendix, Fig. S 3) . Given the many potential sources of variation in response in this cohort, a sufficiently large sample may be required to detect 24 patterns. Nevertheless, for the majority of doses, the clinical response to hydralazine varied over 24 h.
DISCUSSION
Order and first dosing times of antihypertensives, analgesics, anti-infectives, and other drug therapies all followed a 24 h rhythm characterized by a morning surge and an overnight lull.
There are no practice guidelines or institutional policies specifying time-of-day recommendations for any of the drugs in this study. The surge in orders (8 AM-10 AM) coincides with rounding -when the medical care team visits each patient and collaboratively develops a treatment plan. The majority of orders for diagnostics, therapies, and referrals to specialty services are typically placed during rounds or immediately thereafter, once final consensus is reached.
Systemic bias towards treatment at a particular time of day is problematic. Anti-infectives should be administered when an infection is identified, whereas analgesics should be administered when there is pain. Neither of these happen selectively in the morning. In fact, evidence shows that pain is more severe in the evening (8) . Circadian clocks coordinate physiologic functions (9) and affect therapeutic responses according to the time of day (6) . Short-acting antihypertensives taken by millions of adults, for example, are most effective before bedtime (10) . Here, we show that this is also true in the pediatric hospital setting. The clinical response to an acute antihypertensive, hydralazine, varied by 3-4% over 24 h. Paradoxically, patients were more responsive to therapy during the window of time when the fewest doses were ordered and administered.
Conversely, other treatments have shown to be more effective if administered in the morning (vaccines (11) , antipsychotics (12) ), or midday (corticosteroids (13) , radiotherapy (14) , cardiac surgery (15) ). There is no single optimal dosing time for all drugs and patients.
Hospital medical staff are available to provide treatment around the clock, and prevailing dogma is that treatment is given as needed regardless of time of day. Our findings challenge this notion and reveal a potential barrier to best clinical care. Interestingly, studies show that more frequent rounding by nurses can improve measures of patient care (16) . Would medical rounding designed to be more evenly distributed over 24 h improve clinical outcomes? Indeed, there are other long-standing aspects of hospital operation that have been challenged. For example, recent evidence shows that traditional continuous dim lighting in ICUs (17) lacks a medical rationale, disrupts patients, and may impede recovery (18) (19) (20) (21) .
As with all retrospective clinical studies, there were a number of potential sources of variability whose specific contribution could not be evaluated. For example, patient genotype (SNPs can affect hydralazine metabolism (22) ), drug-drug interactions, or special clinical circumstances could each impact the clinical response to hydralazine. We hope that future multicenter prospective trials will further elucidate the importance of drug timing on patient outcomes.
In sum, time of day in hospital operations deserves further consideration.
METHODS

Study design
We performed an observational cohort study of 1,481 patients receiving hydralazine, a commonly used antihypertensive in the ICU, at a tertiary pediatric hospital from Jan 2010 to Dec 2017. All patients receiving hydralazine while admitted to the hospital were included.
Demographic data, medical history, BP, and order and administration times of 12 different drug therapies were recorded. Institutional review board (IRB) approval was obtained prior to initiation of this project.
We analyzed the daily distribution of order and administration times in 1,481 patients who received at least one dose of hydralazine. Although hydralazine treatment was the basis for patient inclusion, our analysis also included 11 other drugs commonly administered to these patients. Patients were diverse in age, sex, race, and diagnoses (Table 1 ). Treatments were administered in ICUs or general floors. Orders for treatment were categorized as "once", "as needed", or "scheduled".
Statistical analyses --tests for uniformity and periodic pattern of orders and doses
For each drug, we tested if 24 h patterns in ordering or administration deviated from a uniform distribution (Kuiper's test (23) ). To avoid bias from scheduled doses ("take every 8 h", for example), we limited analyses to the first dose after each order unless otherwise specified.
To test for 24 h rhythms in treatment, we applied three independent detection methods, cosinor analysis (3) , JTK_CYCLE (4) , and RAIN (5) . For each drug, orders and first-doses were discretized into 2-hour time bins. The amplitude, phase, and overall significance of each rhythmic model is presented in SI Appendix, Table 1 .
Test for daily variation in dosing BP
To analyze BPs associated with hydralazine administration, we identified the BP recording immediately prior to each dose, referred to as the dosing systolic BP (d-SBP). Doses were excluded from analysis if the d-SBP was more than 1 h prior to drug administration.
Test for daily variation in response to hydralazine
We analyzed inpatient responses to hydralazine as a function of dosing time. Table 2 ).
SUPPLEMENTAL INFORMATION Fig S1. Rhythms in orders and first doses across drug classes and hospital units. (A)
Orders and first doses of different drug classes were all non-uniformly distributed over 24 h, the majority with detectable 24 h rhythms (cosinor analysis, P < 0.05, see also SI Appendix, Table   1 ). (B) Daily rhythms in orders and first doses were independent of the hospital treatment unit. 
